Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Ruiz Cobo, Juan Carlos

Ruiz Cobo, Juan Carlos

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital
Ruiz Cobo, Juan Carlos

Ruiz Cobo, Juan Carlos

Ruiz Cobo, Juan Carlos

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

de la Fuente Abelaira, Marisa

de la Fuente Abelaira, Marisa

Administration and Management
Research on Aging, Frailty and Transitions in Barcelona
Read more
José Alegre Martin

José Alegre Martin

Main researcher
Rheumatology
Read more
Griñón Martínez, Jesús

Griñón Martínez, Jesús

Molecular Medical Imaging
Read more
Ángeles Rojas López

Ángeles Rojas López

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.